NYSE Arca · XBI

State Street SPDR S&P Biotech ETF (XBI)

$151.20−3.27%
Close Nov 12, 2026 · split-adjusted
Nov 12, 2026$151.20▲ 32.50% in range
Nov 12, 2025Low $111.91 · High $169.55Nov 12, 2026
What changed · written from our data
As of Nov 12, 2026

State Street SPDR S&P Biotech ETF closed at $151.20 on Nov 12, down 3.27%, 10.8% below its 52-week closing high. Volume of 8.5M shares was 0.92× its 20-day average (close to normal).

Split-adjusted performance: +3.0% over one month, +12.1% over six months, +32.6% over one year.

Short interest was 67.5M shares at the Oct 30 settlement, down 3.5% from the prior report (7.3 days to cover).

Market cap$10.21B67.5M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield0.37%$0.1381 last paid
52-week range111.91 – 169.55−10.8% from high
Volume8.5M0.92× 20-day avg
Volatility · 60d33.6%Annualised
Short % of float—7.3 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W +1.9%1M +3.0%3M −3.9%6M +12.1%YTD +24.0%1Y +32.6%3Y +111.4%5Y +13.5%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short67.5M−3.5% vs prior
Days to cover7.3Settled Oct 30
% of float—
Short vol. 10d65.1%of daily volume

Quick answers

What is XBI's market cap?
$10.21B, based on the Nov 12 close of $151.20.
Does State Street SPDR S&P Biotech ETF pay a dividend?
Yes. The latest regular dividend was $0.1381 per share (ex-date Jun 22), an annualised yield of 0.37%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology